EHD2 Antikörper (N-Term)
-
- Target Alle EHD2 Antikörper anzeigen
- EHD2 (EH-Domain Containing 2 (EHD2))
-
Bindungsspezifität
- N-Term
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser EHD2 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB)
- Sequenz
- SFIQYLLEQE VPGSRVGPEP TTDCFVAVMH GDTEGTVPGN ALVVDPDKPF
- Aufreinigung
- Affinity purified
- Immunogen
- The immunogen is a synthetic peptide directed towards the N terminal region of human EHD2
- Top Product
- Discover our top product EHD2 Primärantikörper
-
-
- Applikationshinweise
- Optimal working dilution should be determined by the investigator.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Buffer
- Liquid. Purified antibody supplied in 1x PBS buffer with 0.09 % (w/v) sodium azide and 2 % sucrose.
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- For short term use, store at 2-8°C up to 1 week. For long term storage, store at -20°C in small aliquots to prevent freeze-thaw cycles.
-
- Target
- EHD2 (EH-Domain Containing 2 (EHD2))
- Andere Bezeichnung
- EHD2 (EHD2 Produkte)
- Hintergrund
-
This gene encodes a member of the EH domain-containing protein family. These proteins are characterized by a C-terminal EF-hand domain, a nucleotide-binding consensus site at the N terminus and a bipartite nuclear localization signal. The encoded protein interacts with the actin cytoskeleton through an N-terminal domain and also binds to an EH domain-binding protein through the C-terminal EH domain. This interaction appears to connect clathrin-dependent endocytosis to actin, suggesting that this gene product participates in the endocytic pathway.
Alias Symbols: PAST2
Protein Size: 543 - Gen-ID
- 30846
- NCBI Accession
- NM_014601, NP_055416
- UniProt
- Q9NZN4
- Pathways
- Regulation of Muscle Cell Differentiation, Skeletal Muscle Fiber Development
-